Amplifon Acquires GN ReSound - What This Means for Your Practice

Last week, Amplifon made a huge strategic play by announcing plans to acquire GN Hearing in a $2.64 billion deal, which is expected to close by the end of 2026 pending regulatory approval. This means that the world's largest hearing aid retailer will now own their own manufacturing, R&D and retail distribution, creating a fully integrated hearing care powerhouse that covers 100+ countries, generates €3.3B and gives them full end-to-end delivery. This creates both a risk for private hearing care practices, and an opportunity for private practice. Because, from next year, what we're going to see is a significantly wider gapbetween the corporate side of the market (the big hairy Goliath of Amplifon) and the independent private practice side of the market (the David). The problem is, if a private practice clinic attempts to play the Goliaths game by competing on price, trying to serve the wider mass market, and continuing to tell the "we sell hearing aids" story ... they're going to get utterly squashed.